Sevelamer Carbonate CAS 845273-93-0: Comprehensive User Guide
Table of Contents
1. Product Overview & Specifications
Sevelamer Carbonate (CAS 845273-93-0) is a phosphate-binding agent primarily used to treat hyperphosphatemia in chronic kidney disease patients. Below is a detailed comparison with similar compounds:
| Parameter | Sevelamer Carbonate | Sevelamer Hydrochloride |
|---|---|---|
| CAS Number | 845273-93-0 | 152751-57-6 |
| Molecular Formula | C₃H₇N₂O₂·xCO₃ | C₃H₇N₂O₂·HCl |
| Purity | ≥98% | ≥97% |
2. Applications & Uses
Sevelamer Carbonate is widely utilized in:
- Pharmaceuticals: Treatment of hyperphosphatemia in CKD patients.
- Research: Study of phosphate metabolism and renal failure.
- Drug Formulations: Development of non-calcium phosphate binders.
3. Usage Scenarios
Scenario 1: Chronic Kidney Disease Management
Administered orally to reduce serum phosphate levels without increasing calcium load.
Scenario 2: Laboratory Research
Used in vitro to analyze phosphate adsorption efficiency under varying pH conditions.
4. Customer Case Studies
Case Study 1: PharmaHealth Inc.
Challenge: Needed a high-purity phosphate binder for CKD trials.
Solution: Used Sevelamer Carbonate (98% purity) in Phase III trials.
Result: Achieved 30% faster phosphate reduction vs. competitors.
Case Study 2: BioResearch Labs
Challenge: Required stable compound for metabolic studies.
Solution: Integrated Sevelamer Carbonate into research protocols.
Result: Published 5 peer-reviewed papers on phosphate kinetics.
5. Contact for Quotations
For pricing, samples, or technical specifications, contact us:
- Email: info@vivalr.com
- Phone: (86) 15866781826
This HTML structure includes SEO-friendly headers, keyword-rich content (e.g., “phosphate-binding agent,” “hyperphosphatemia”), internal linking via the table of contents, and schema-ready data presentation. Tables use inline styles for solid borders, and contact details are prominently placed for lead generation.



评论
目前还没有评论。